Real-World Promise of Cilostazol in Refractory Vasospastic Angina: The Need for Multicentre Collaboration
Cardiology · 09.06.2026 · 1-2
DOI: 10.1159/000552955 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cardiology, online erschienen am 09.06.2026. Verfasst von Adnan Duha Cömert und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ahi Evren Training and Research Hospital, Trabzon, Turkey, adnanduhacomert@outlook.com.tr. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Ahi Evren Training and Research Hospital, Trabzon, Turkey, adnanduhacomert@outlook.com.tr.
- Department of Cardiology, University of Health Sciences Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey.
Zitieren
APA
Cömert, A. D., & Taştan, E. (2026). Real-World Promise of Cilostazol in Refractory Vasospastic Angina: The Need for Multicentre Collaboration. Cardiology, 1-2. https://doi.org/10.1159/000552955
Vancouver
Cömert AD, Taştan E. Real-World Promise of Cilostazol in Refractory Vasospastic Angina: The Need for Multicentre Collaboration. Cardiology. 2026:1-2. doi:10.1159/000552955
BibTeX
@article{Cmert2026,
author = {Cömert, Adnan Duha and Taştan, Ercan},
title = {Real-World Promise of Cilostazol in Refractory Vasospastic Angina: The Need for Multicentre Collaboration},
journal = {Cardiology},
year = {2026},
pages = {1--2},
doi = {10.1159/000552955}
}
EUVIMED